An Observational Study to Learn More About NTRK Gene Fusion Positive in Solid Tumor in Japan

CompletedOBSERVATIONAL

Enrollment

46,621

Participants

Timeline

Start Date

March 10, 2023

Primary Completion Date

September 28, 2023

Study Completion Date

September 28, 2023

Conditions

Advanced or Recurrent Solid Tumor Harboring an NTRK Gene Fusion

Interventions

OTHER

No Drug

Retrospective data analysis, the dataset for this study will be extracted from the C-CAT database.

Trial Locations (1)

Many Locations, Multiple Locations